Patents for C07D 319 - Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms (10,283) |
---|
05/15/2002 | CN1349522A Salts of 2,2-dimethyl-1,3-dioxide intermediates and process for the prepn. thereof |
05/15/2002 | CN1084619C Process for preparing medicine composition |
05/14/2002 | US6388134 Chemical intermediates |
05/14/2002 | US6388074 Process for the preparation of purine derivatives |
05/14/2002 | CA2092997C Process for the synthesis of (4r-cis)-1, 1-dimethylethyl 6-cyanomethyl-2,2-dimethyl-1, 3-dioxane-4-acetate |
05/10/2002 | WO2002036555A1 Sulfamides as gamma-secretase inhibitors |
05/08/2002 | EP1203761A2 Calcium receptor-active compounds |
05/08/2002 | EP1202953A2 Substituted 2-dialkylaminoalkylbiphenyl derivatives |
05/08/2002 | DE10151492A1 Novel difluoroacrylic acid derivatives are useful as components in liquid crystalline media |
05/08/2002 | CN1348441A N-substituted arylsulfonyl-lamino hydroxamic acids |
05/07/2002 | US6384243 Enzymatic conversion of unsaturated fatty acid; cider apple; linoleic acid |
05/07/2002 | US6384241 Purified salt of β-hydroxyethoxy acetic acid, purified 2-p-dioxanone, and manufacturing method therefor |
05/07/2002 | US6384230 2,6-dimethyl-5-((4-ethoxyphenyl)-methoxy)-7-(2-methylthiazol-4-yl)hepta -2,6-dienoic acid ethyl ester from malic acid, wittig reaction with 2-methyl-4-thiazolylmethyl triphenyl phosphonium bromide; intermediates for epothilone a or b |
05/07/2002 | US6384085 Antioxidative ingredients extracted from powdered ecklonia cava one or more times with organic solvent, fractionated one or more times in solvents, and purified by chromatography |
05/07/2002 | US6384075 Treating diseases in which mast cell dysfunction is involved |
05/07/2002 | US6384036 Bis-sulfonamide hydroxyethylamino retroviral protease inhibitors |
05/07/2002 | US6384030 Water soluble azoles as broad-spectrum antifungals |
05/02/2002 | US20020052515 Ammonium 3,5,6-trihydroxyhexanoate derivatives and preparation process thereof |
05/02/2002 | US20020052417 Factor VIIa inhibitory (thio)urea derivatives, their preparation and their use |
05/02/2002 | US20020052400 Substituted O- and/or S heterocyclic compounds; powerful ligands for melatoninergic receptors. |
05/02/2002 | US20020052378 Novel compounds and compositions as protease inhibitors |
05/02/2002 | US20020052028 Bio-intermediates for use in the chemical synthesis of polyketides |
05/02/2002 | EP1201650A2 Ionic malonitril derivatives and their uses |
04/30/2002 | US6380403 Illudin analogs useful as antitumor agents |
04/30/2002 | US6380188 For inhibiting human immunodeficiency virus protease |
04/30/2002 | CA2059787C Hydrazine derivative and pesticidal composition comprising said derivative as an effective ingredient |
04/25/2002 | WO2002032872A1 Nitrogenous aromatic ring compounds |
04/25/2002 | WO2002032373A2 Estrogen receptor modulators |
04/25/2002 | US20020049221 Analogs of deoxypreussomerin, palmarumycin CPI and related naphthoquinone spiroketals; inhibit thioredoxin-thioredoxin reductase system |
04/25/2002 | US20020049201 Sulfonamide inhibitors of aspartyl protease |
04/25/2002 | US20020049135 Catalysts containing per-ortho aryl substituted aryl or heteroaryl substituted nitrogen donors |
04/25/2002 | CA2424726A1 Estrogen receptor modulators |
04/24/2002 | EP1199304A1 Bicyclic compounds and pharmaceutical composition containing tricyclic compound for treating or preventing sleep disorders |
04/24/2002 | EP1198234A2 Bicyclic aromatic compounds for treating drug addiction |
04/24/2002 | CN1083448C 1-phenyl-4-benzylpiperazines: dopamine receptor subtype specific ligands (D4) |
04/23/2002 | US6376535 Oxygen-containing heterocyclic compounds |
04/23/2002 | US6376494 Cycloalkyl-substituted aryl-piperazines, piperidines and tetrahydropyridines as serotonergic agents |
04/23/2002 | US6376428 Dihalopropene compounds, insecticidal/acaricidal agents containing same, and intermediates for their production |
04/18/2002 | WO2002030929A1 Novel pleuromutilin derivatives |
04/17/2002 | EP1196406A1 Amino ceramide-like compounds and therapeutic methods of use |
04/17/2002 | EP1196373A1 3-amino-2-benzyl-1-phenyl-propane derivatives |
04/16/2002 | US6372693 Substituted 2-(3-alkenyl-benzoyl)-cyclohexane-1,3-diones |
04/16/2002 | US6372682 Contacting one or more olefin monomers with a group 8-10 transition metal complex catalyst and optionally a bronsted or lewis acid |
04/16/2002 | US6372153 Fluoroalkoxybenzene derivatives having ether bond, liquid-crystal composition, and liquid-crystal display element |
04/16/2002 | CA2143252C Benzodioxanes derivatives; process for preparing the same and pharmaceutical compositions containing them |
04/11/2002 | WO2002028823A1 Malonamid and malonamic ester derivatives with antithrombotic activity, their preparation and their use |
04/11/2002 | WO2002028820A1 Nitroso diphenylamine derivatives |
04/11/2002 | WO2002028776A1 Rare earth or gallium additive composition, methods for preparing same and use thereof as catalyst |
04/11/2002 | WO2002028396A1 Formulations for reducing or eliminating toxicity of environmental hormones containing ursodeoxycholic acid |
04/11/2002 | US20020042531 Polymers derived from an unsaturated fused cyclic hydrocarbon (such as perhydro-2,3-didehydro-1,4:5,8-dimethanonaphthalene) joined by a linker to an ester group having one or two protected hydroxyls; use as photoresist |
04/11/2002 | DE10141565A1 Cyclobutanone compounds useful in liquid crystal media, especially for plasma-addressed displays, comprises substituted trans-cyclohexylene, p-phenylene and-or other cyclic groups, |
04/11/2002 | DE10047118A1 Verfahren zur Herstellung von Ketocarbonsäurederivaten Process for the preparation of ketocarboxylic acid derivatives |
04/11/2002 | CA2424925A1 Rare earth or gallium additive composition, methods for preparing same and use thereof as catalyst |
04/11/2002 | CA2424684A1 Nitroso diphenylamine derivatives |
04/10/2002 | EP0937063B1 Aryloxypropanolamine derivatives, method of preparation and applications thereof |
04/10/2002 | CN1344265A Piperidine, tetrahydropyridine and piperazine derivatives, their prepn. and use |
04/10/2002 | CN1343668A Process for synthesizing cyclic carbonate |
04/04/2002 | WO2001094301A3 Factor viia inhibitory (thio)urea derivatives, their preparation and their use |
04/03/2002 | EP1193248A1 Malonamid and malonamic ester derivatives with antithrombotic activity, their preparation and their use |
04/03/2002 | EP1192205A1 Catalyst composition and use thereof |
04/02/2002 | US6365756 Ketalisation by condensing with acetone; recrystallisation; optical resolution of the mixture of enantiomers by dissolving in a chiral tartaric acid derivative; |
04/02/2002 | US6365755 Ammonium 3,5,6-trihydroxyhexanoate derivatives and preparation process thereof |
04/02/2002 | US6365068 Heterocyclic aromatic anion salts, and their uses as ionic conducting materials |
04/02/2002 | CA2178130C Method of producing 2-naphthamide derivative, and compounds for producing 2-naphthamide derivative |
03/28/2002 | WO2002024632A2 Substituted aminopropoxyaryl derivatives useful as agonists for lxr |
03/28/2002 | WO2002024622A1 Method for producing ketocarboxylic acid derivatives |
03/28/2002 | WO2002024613A2 Resorcinol derivatives |
03/28/2002 | US20020038025 For therapy and prophylaxis of hypercholesterolemia, hyperlipemia, arteriosclerosis, vascular diseases, mycoses, parasite infections, gallstones, tumors and/or hyperproliferative disorders, diabetes |
03/28/2002 | CA2423262A1 Resorcinol derivatives |
03/27/2002 | EP1191611A2 Piezoelectric element and process for production thereof |
03/27/2002 | EP1191023A1 Method of making dihydroperimidine squaraine compounds |
03/27/2002 | EP1191020A2 Material for organic electroluminescence device and use thereof |
03/27/2002 | EP0934253B1 Halogenalkoximinoacetamide |
03/27/2002 | EP0651746B1 Drugs that enhance synaptic responses mediated by ampa receptors |
03/27/2002 | CN1342152A N-substituted imide derivatives with serotonergic activity |
03/26/2002 | US6362177 Cyclic amine derivatives and their use as drugs |
03/26/2002 | US6361713 Displacing water from and decontaminating surfaces |
03/26/2002 | CA2041588C Cyclohexenone oxime ethers, their preparation, intermediates for their preparation and their use as herbicides |
03/21/2002 | WO2002022694A1 Catalysts containing per-ortho aryl substituted aryl or heteroaryl substituted nitrogen donors |
03/21/2002 | WO2002022556A1 Novel amide derivatives and medicinal use thereof ugs |
03/21/2002 | WO2002022240A1 The plasma assisted catalytic treatment of gases |
03/21/2002 | WO2001096278A3 A novel process for preparing salmeterol |
03/21/2002 | US20020035274 Process for producing simvastatin and/or its derivatives |
03/21/2002 | US20020035137 Amino (oxo) acetic acid protein tyrosine phosphatase inhibitors |
03/21/2002 | US20020035136 Amino(oxo) acetic acid protein tyrosine phosphatase inhibitors |
03/21/2002 | US20020035114 Substituted dimeric compounds |
03/21/2002 | US20020035113 Piperidine, tetrahydropyridine and piperazine derivatives, their preparation and use |
03/21/2002 | US20020035030 Contacting alpha-olefin with ransition metal complex of and Bronsted or Lewis acid to produce polyolefin |
03/21/2002 | US20020033472 Difluorovinyl compound, liquid crystal composition and liquid crystal display |
03/21/2002 | CA2421054A1 Catalysts containing per-ortho aryl substituted aryl or heteroaryl substituted nitrogen donors |
03/20/2002 | EP1187798A1 PRODUCTION OF OPTICALLY ACTIVE $g(a)-HYDROXYACETALS |
03/20/2002 | EP0929508B1 Liquid crystalline (e,e)-butadiene compounds and mixtures and devices containing such compounds |
03/14/2002 | WO2002020528A2 Fluorinated and alkylated alditol derivatives and polyolefin articles containing same |
03/14/2002 | WO2002020510A1 Acid-sensitive compounds, preparation and uses thereof |
03/14/2002 | US20020030179 Having negative and large dielectric anisotropy value and small optical anisotropy value at the same time |
03/14/2002 | CA2421179A1 Acid-sensitive compounds, preparation and uses thereof |
03/13/2002 | EP1186594A1 N-alkoxyalkyl-n,n-dialkylamine derivatives or salts thereof, and remedies for nerve degeneration diseases containing the same |
03/13/2002 | EP0869957B1 3(2h)-pyridazinone derivatives and pharmaceutical compositions containing these compounds |
03/13/2002 | CN1340052A Process for the production of tert-butyl (E)-(6[2-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino] pyrimidin 5-yl] (4R,6S)-2,2-dimethyl [1,3] dioxan-4-yl) acetate |
03/12/2002 | US6355634 Aromatic compounds |